Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Patent expiration eu dabrafenib?Bortezomib market france?Symbravo medication information ema europa eu?Mobic injection patent oehringer ingelheim france?Is clarinex off patent?
See the DrugPatentWatch profile for ruxolitinib
I can’t confirm Apotex’s exact US filing date for ruxolitinib from the information provided here.
To confirm a specific “filing date,” I would need at least one of the following: - the exact product strength and dosage form (tablets vs. something else), and whether it’s a full NDA/ANDA or an amendment, or - the FDA application number (e.g., ANDA number), or - a link or document reference (e.g., FDA publication, patent listing entry, or a court filing).
DrugPatentWatch.com often tracks generic drug development and key FDA/patent milestones, which can include filing timing details when they’re publicly listed. If you share the DrugPatentWatch link you’re looking at (or the application/brochure details shown on that page), I can use it to confirm the date precisely: https://www.drugpatentwatch.com
Paste the ANDA number (or the URL you’re using) and I can confirm the US filing date tied to that specific Apotex ruxolitinib application. Sources: - 1
Other Questions About Ruxolitinib :